Pfizer, Inc. vs TransMedics Group, Inc. — Stock Comparison
Q·Score Breakdown
6.5
Neutral
Overall
8.8
Very Bullish
Quality
Health
Growth
Valuation
Sentiment
PFE
Strong profitability with 12% net profit margins.
⚠ analyst sentiment is cautious.
TMDX
Earnings growing 1188% year-over-year on 32% revenue growth.
Analyst Consensus
HOLD
Target $29.00 (+10.2%)
27 analysts
BUY
Target $156.00 (+56.0%)
10 analysts
Fundamentals
PFE
TMDX
19.4×
Trailing P/E
20.5×
9.4×
Forward P/E
27.2×
12.4%
Profit Margin
31.4%
75.8%
Gross Margin
59.9%
8.9%
ROE
54.2%
-1.2%
Revenue Growth
32.2%
—
Earnings Growth
1188.1%
0.39
Beta
2.08
—
Price / Book
—
$149.8B
Market Cap
$3.5B
$22 – $29
52-Week Range
$90 – $156
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →